Healthcare Staffing Industry Digest: May 25 - May 29, 2026
Executive Summary
The Valuation Standoff and the Platform War: Before you dive into this week’s intelligence digest, here are the macro trends actively reshaping our industry today:
The Valuation Standoff: TrueBlue’s unanimous rejection of HireQuest’s $105M bid for its On-Demand business signals a growing gap between what strategic buyers are willing to pay and what management teams believe distressed staffing assets are worth. With Cross Country going private at a compressed multiple and TrueBlue defending its valuation publicly, mid-market staffing M&A is entering a period of contested pricing that will define deal activity through the second half of 2026.
The Platform War: PeopleScout, AMN, and Cross Country all made material AI platform moves this week, from opening Affinix® to direct client access to marketing TRIAGE actively to health system buyers. The competitive axis in healthcare staffing has shifted from clinician supply to workforce intelligence, and the platforms that win deep system integration in 2026 will be structurally difficult to displace.
The Strike Windfall Hangover: AMN’s $1.378B Q1 2026 revenue included $722M in labor disruption revenue that will not repeat in Q2, where guidance sits at $620–$635M. The Q2 step-down returns AMN to baseline, and the genuine recovery test begins there. Underlying growth in travel nursing and international staffing is encouraging, but the headline-to-baseline drop is significant, and the sector will be watching closely.
The Post-Acute Bifurcation: Congress has permanently codified Acute Hospital Care at Home, projecting a $6B–$21.5B market by 2034, while CMS reimbursement changes are simultaneously creating acute pressure on franchise-based home health operators. Post-acute is not a single market. It is diverging quickly, and staffing organizations need clear positioning in which segments they are built to serve.
The Structural Supply Signal: AMN survey data puts average primary care appointment wait times at 31 days, a 48% increase from prior benchmarks. That physician supply gap is not a cyclical problem. It is the structural driver underneath every workforce strategy conversation in healthcare right now, and it is getting worse.
Dive into this week’s digest below to see exactly how the market’s biggest players are navigating these shifts.
Headlines for the Week
M&A / Partnerships
TrueBlue Board Unanimously Rejects HireQuest’s $105M Bid for On-Demand Business
Previously covered: The May 22 digest reported HireQuest’s unsolicited $105M acquisition proposal for TrueBlue’s On-Demand segment, with TrueBlue’s board yet to formally respond.
Why it matters this week: TrueBlue’s board unanimously rejected the proposal on May 27, characterizing it as materially undervaluing the business and closing the first round of what may become a prolonged public contest for the segment’s future.
A unanimous board rejection signals that TrueBlue’s leadership sees significantly more recovery value in On-Demand than HireQuest’s opening bid captures. The public nature of the vote puts the next move entirely with HireQuest: a revised bid, a proxy contest, or a withdrawal, each of which carries distinct implications for TrueBlue’s strategic trajectory in the second half of 2026.
Read about the TrueBlue board rejection
Financial Results
AMN Healthcare Q1 2026: $1.378B Revenue Includes $722M Strike Windfall; Q2 Guided at $620–$635M
Previously covered: The May 8 digest reported AMN’s Q1 2026 results in full, including the $722M in labor disruption revenue, $166M adjusted EBITDA, and Q2 2026 guidance of $620–$635M.
Why it matters this week: New AMN survey data shows primary care appointment wait times have reached 31 days, up 48% from prior benchmarks, adding a fresh supply signal: the structural physician shortage is intensifying even as the financial volatility of strike revenue fades from the picture.
Strip out the labor disruption revenue, and AMN’s underlying Q1 run rate was approximately $656M, closely in line with prior quarters. Genuine recovery is present, with international staffing posting its first YoY growth since Q4 2023 and travel nursing showing its first YoY gain since 2022, but the Q2 guided range confirms the sector’s base-level recovery is measured rather than accelerating.
Read about the AMN Q1 2026 earnings
Product / Platform News
PeopleScout Opens Affinix® to Direct Client Access, Expanding AI Talent Platform Beyond Managed RPO
PeopleScout’s decision to give RPO clients direct access to Affinix® shifts the platform from a managed service tool to a co-piloted talent intelligence system, enabling client recruiting teams to operate the AI-powered platform independently. This move positions PeopleScout to compete directly with standalone talent technology vendors and retain clients who might otherwise seek a pure-play ATS or AI sourcing solution outside of an RPO relationship.
Read about the Affinix® direct client access launchAMN’s TRIAGE Platform Moves from Internal Deployment to Active Health System Sales
AMN’s TRIAGE workforce optimization platform is now being actively marketed to health system clients through direct channels, signaling a shift from internal deployment to an external product offering. For AMN, converting TRIAGE into a client-facing platform product is a critical revenue diversification move as the Technology and Workforce Solutions segment faces guided Q2 declines of 14–16% YoY.
Read about the AMN TRIAGE platform signal
Executive Commentary / Industry Trends
SIA: US Staffing Hours Up 4% YoY for Third Consecutive Week; Americas Market Projected at $197B with 1.1% Growth in 2026
Three consecutive weeks of positive YoY growth in US staffing hours is a confirmation signal, not a one-week anomaly, with commercial staffing leading at +6% and professional staffing at +3%. SIA’s Americas market forecast of $197B with 1.1% US growth in 2026 confirms a floor has been established after the multi-year post-pandemic correction, even if the trajectory remains modest.
Read about the SIA/Bullhorn Staffing IndicatorSIA Travel Nurse Benchmarking: Signs of Stability, but Profitability Challenges Remain the Defining Headwind
SIA’s NATHO travel nurse benchmarking survey confirms the volume stabilization that public company earnings have been signaling while identifying persistent margin compression as the sector’s primary unresolved challenge. Volume recovery without margin recovery does not translate into business health for most travel staffing operators, and Q2 2026 earnings will be the first clean test of how much of the profitability gap has actually closed.
Read about the SIA travel nurse benchmarkingConsolidated Appropriations Act of 2026 Locks In Acute Hospital Care at Home: A $6B–$21.5B Market by 2034
Congress has permanently codified the CMS Acute Hospital Care at Home program with expanded patient eligibility, Medicare reimbursement parity, and new coverage for remote patient monitoring devices, projecting a 17.16% CAGR through 2034. For staffing organizations, this is not a trend to monitor but a structural market to enter: hospital-at-home programs require a distinct clinical staffing profile that does not map cleanly onto existing travel nursing or traditional home health infrastructure. Simultaneously, CMS reimbursement changes are creating acute pressure on franchise-based home health operators, reinforcing that post-acute is bifurcating fast between segments that are expanding and segments that are contracting.
Read about the Acute Hospital Care at Home legislationPeopleScout Earns Leader Designation in NelsonHall’s Global RPO NEAT Evaluation
NelsonHall NEAT ratings are among the more credible independent assessments in the RPO market, and a Leader designation strengthens PeopleScout’s position in enterprise sales conversations. The recognition arrives in the same week as the Affinix® direct client access launch, reinforcing a consistent platform maturity narrative that is increasingly competitive against pure-play talent technology vendors.
Read about the PeopleScout NEAT Leader designation
Leadership Changes
Soliant Health Names Randstad Executive Graig Paglieri as CEO, Effective May 26
Paglieri brings enterprise-scale leadership experience from Randstad into Soliant Health’s executive suite, while founder David Alexander moving to Vice Chairman signals a deliberate succession rather than a clean break from the company’s culture. The transition raises the question of whether Soliant is preparing for institutional growth, a capital event, or a sale under new leadership.
Read about the Soliant Health CEO appointmentProlink Promotes Abby Zimmerman from SVP of People & Process Transformation to Chief Operating Officer
Zimmerman’s trajectory from recruiter to COO in thirteen years is both a retention story and an organizational signal: Prolink is building its operational leadership from within rather than importing it. An internal COO appointment at a growth-stage healthcare staffing firm typically indicates readiness to scale operations without a leadership transition period.
Read about the Prolink COO promotionTrueBlue Appoints Chris Kreidler as Board Chair, Effective May 12
Kreidler’s elevation to Board Chair during an active, unsolicited acquisition attempt is a governance signal as much as a leadership decision. The appointment positions TrueBlue’s board to respond cohesively to what may become a prolonged strategic contest, indicating the company is organizing for a deliberate response rather than operating reactively to HireQuest’s pressure.
Read about the TrueBlue board chair appointment
On Our Radar
These are the developments we are tracking closely heading into next week and why they matter for the sector.
Cross Country / Knox Lane Close Timeline: The $437M take-private remains pending regulatory and shareholder approvals, with CCRN shares trading at $13.09 against the $13.00 offer. Minimal trading premium suggests the market expects no competing bid, pointing to Q3 2026 as the base-case close window.
TrueBlue / HireQuest Next Move: TrueBlue’s unanimous board rejection puts the decision squarely with HireQuest. A revised bid, a proxy fight, or a withdrawal each carries distinct implications for how the On-Demand segment’s future is resolved, and the timeline will shape TrueBlue’s strategic posture for the rest of 2026.
Nomad Health Platform-Only Execution: Nomad has completed its exit from direct staffing operations. The open question is whether partner agency volume and clinician adoption of the software-only model will scale quickly enough to sustain relevance in a sector that has historically rewarded direct relationships over aggregation platforms.
Travel Nursing Margin Recovery: SIA’s NATHO data confirms volume stabilization but persistent profitability pressure across travel nursing operations. Q2 2026 earnings from AMN, Cross Country, and Ingenovis will be the first clean read on whether margin recovery is materializing or whether the sector is stabilizing at compressed economics.
AI Platform Competition: Cross Country’s Intellify® with Optimé integration, TrueBlue’s Affinix®, and AMN’s TRIAGE are now in active competition for health system workforce intelligence contracts. The first major health system platform consolidation decisions in H2 2026 will signal which architecture is winning the buying cycle.
